Companies have paid-up licenses to make and sell the respective lines of products.
Cepheid and Idaho Technology have agreed to resolve a dispute related to their intellectual property, through a settlement and cross-license agreement.
The agreement will lead to the dismissal of a lawsuit initiated by Idaho Technology and its licensor, University of Utah Research Foundation, in 2005. The dispute claimed infringement of three patents related to rapid PCR methods and instrumentation, the use of SYBR® Green I in PCR reactions, and certain methods of analysis of real-time PCR data.
As part of the settlement Cepheid will make a one-time payment to Idaho of $3.35 million. Each firm will have paid-up licenses under certain of the other’s patents to continue to make and sell their respective lines of products.
